ArticleInternational journal of molecular sciences2022

JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells.

Yunmoon Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.